v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 65,116 $ 113,984
Restricted cash, current 519 521
Financial assets:    
Accounts receivable 10,036 31,904
Contract assets 815 2,116
Unbilled receivables 9,142  
Total financial assets 19,993 41,036
Less: allowances (65) (163)
Total financial assets, net 19,928 40,873
Inventories 2,685 2,029
Prepaid expenses and other current assets 5,218 5,487
Total current assets 93,466 162,894
Restricted cash 1,062 1,521
Investment in non-marketable equity securities ($0 and $13,921 with a related party) 9,700 20,510
Right-of-use assets - Operating leases, net 13,137 39,263
Property and equipment, net 15,487 22,614
Goodwill 2,463 3,241
Other non-current assets 1,246 350
Total assets 136,561 250,393
Current liabilities:    
Accounts payable 5,947 3,246
Accrued compensation 11,246 11,453
Other accrued liabilities 4,735 15,279
Current portion of lease obligations - Operating leases 10,121 13,728
Deferred revenue 3,781 5,360
Total current liabilities 35,830 49,066
Deferred revenue, net of current portion 640 16,881
Long-term lease obligations - Operating leases 12,243 38,278
Other long-term liabilities 1,233 1,371
Total liabilities 49,946 105,596
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 5,000 shares authorized, none issued and outstanding 0 0
Common stock, $0.0001 par value per share; 200,000 shares authorized; 69,905 and 65,811 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 7 6
Additional paid-in capital 584,138 566,081
Accumulated deficit (497,530) (421,290)
Total stockholders’ equity 86,615 144,797
Total liabilities and stockholders’ equity $ 136,561 $ 250,393

Source